{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:35:00Z","timestamp":1787596500302,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ijrobp.2015.10.061","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:57:33Z","timestamp":1446685053000},"page":"544-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Pathologic Response, When Increased by Longer Interval, Is a Marker but Not the Cause of\u00a0Good Prognosis in Rectal Cancer: 17-year Follow-up of the Lyon R90-01 Randomized Trial"],"prefix":"10.1016","volume":"94","clinical-trial-number":[{"clinical-trial-number":"nct01333709","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01648894","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02505750","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Eddy","family":"Cotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Passot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2412-4767","authenticated-orcid":false,"given":"Evelyne","family":"Decullier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Lorchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chapet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2599-8140","authenticated-orcid":false,"given":"Jean-Pierre","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2015.10.061_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijrobp.2012.05.017","article-title":"Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy","volume":"85","author":"Appelt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: A cohort study in the US SEER cancer registries","volume":"12","author":"Berrington de Gonzalez","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(13)70599-0","article-title":"Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: Long-term results of the EORTC 22921 randomised study","volume":"15","author":"Bosset","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib4","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib5","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1200\/JCO.2007.15.3858","article-title":"Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer","volume":"26","author":"Braendengen","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ejca.2011.06.035","article-title":"Health-related quality of life (HRQOL) after multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a phase III study","volume":"48","author":"Braendengen","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","article-title":"Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer","volume":"93","author":"Bujko","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.canrad.2010.03.009","article-title":"Second primitive malignant neoplasm after radiotherapy","volume":"14","author":"Doyen","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib9","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1200\/JCO.2005.08.144","article-title":"Swedish rectal cancer trial: Long lasting benefits from radiotherapy on survival and local recurrence rate","volume":"23","author":"Folkesson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib10","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1200\/JCO.1999.17.8.2396","article-title":"Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial","volume":"17","author":"Francois","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib11","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1200\/JCO.2012.42.8771","article-title":"Clinical outcome of the ACCORD 12\/0405 PRODIGE 2 randomized trial in rectal cancer","volume":"30","author":"Gerard","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib12","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2009.25.8376","article-title":"Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12\/0405-PRODIGE 2","volume":"28","author":"Gerard","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib13","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1200\/JCO.2004.08.170","article-title":"Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The Lyon R96-02 randomized trial","volume":"22","author":"Gerard","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib14","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in t3-4 rectal cancers: Results of FFCD 9203","volume":"24","author":"Gerard","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.critrevonc.2011.02.001","article-title":"Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: Lessons from a systematic review of recent randomized trials","volume":"81","author":"Gerard","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib16","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/bjs.4162","article-title":"Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer","volume":"90","author":"Glehen","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib17","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ijrobp.2013.12.012","article-title":"Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: Impact of salvage therapy on local disease control","volume":"88","author":"Habr-Gama","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib18","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/DCR.0b013e3182a25c4e","article-title":"Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: Are we getting closer to anal cancer management?","volume":"56","author":"Habr-Gama","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.coc.0000258084.55036.9e","article-title":"A population-based analysis of second primary cancers after irradiation for rectal cancer","volume":"30","author":"Kendal","year":"2007","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib20","doi-asserted-by":"crossref","first-page":"N51","DOI":"10.1088\/0952-4746\/32\/1\/N51","article-title":"Radiation and cancer risk in atomic-bomb survivors","volume":"32","author":"Kodama","year":"2012","journal-title":"J Radiol Prot"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/1471-2407-13-417","article-title":"A multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): Rationale and design","volume":"13","author":"Lefevre","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib22","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/bjs.8821","article-title":"Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for t2\u00a0rectal cancer after neoadjuvant therapy","volume":"99","author":"Lezoche","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijrobp.2013.02.020","article-title":"Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer","volume":"86","author":"Mohiuddin","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib25","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/j.ijrobp.2011.12.002","article-title":"Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R96-02 randomized trial","volume":"83","author":"Ortholan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00423-011-0890-8","article-title":"Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer\u2013Treatment results at 5-year follow-up","volume":"397","author":"Pach","year":"2012","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib27","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years","volume":"30","author":"Sauer","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/bjs.9112","article-title":"Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer","volume":"100","author":"Sloothaak","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1667\/RR0527.1","article-title":"Secondary carcinogenesis in patients treated with radiation: A review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects","volume":"167","author":"Suit","year":"2007","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2015.10.061_bib30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled tme trial","volume":"12","author":"van Gijn","year":"2011","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615266679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615266679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T21:21:45Z","timestamp":1537219305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301615266679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0360301615266679"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.10.061","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathologic Response, When Increased by Longer Interval, Is a Marker but Not the Cause of\u00a0Good Prognosis in Rectal Cancer: 17-year Follow-up of the Lyon R90-01 Randomized Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.10.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}